Top Industry News

Ono Pharmaceutical, an Osaka, Japan-based bio/pharmaceutical company, has agreed to acquire Deciphera Pharmaceuticals, a Waltham, Massachusetts-based bio/pharmaceutical company, for $2.4 billion.  The pending acquisition would add to Ono’s oncology operations…

Novartis has agreed to acquire Mariana Oncology, a Watertown, Massachusetts-based bio/pharmaceutical company developing radioligand therapies (RLTs) to treat cancers, in a deal worth up to $1.75 billion ($1 billion upfront…

AbbVie has broken ground on a new central research building in Ludwigshafen, Germany, and is investing approximately EUR 150 million ($160 million) in its second largest R&D location worldwide.   A…

Emergent BioSolutions, a Gaithersburg, Maryland-based specialty bio/pharmaceutical company and contract manufacturer, has announced the next phase of its new operational plan that consolidates operations, closes several manufacturing facilities, and restructures…

The latest from CDMOs, CMOs, and suppliers featuring Adare Pharma Solutions, Cytiva, PCI Pharma Services, and PharmaLogic.   Chemicals/Chemical API Manufacturing * PharmaLogic Opens Radiopharmaceutical Mfg Facility   Biologics Manufacturing * Cytiva Adds New…

Novartis has proposed Dr. Giovanni Caforio, ex-CEO and Executive Chairman of Bristol Myers Squibb, as Chair of the company’s Board of Directors.  The election to decide the next chair of Novartis’…

Eli Lilly and Company has agreed to acquire a manufacturing facility in Pleasant Prairie, Wisconsin, from Nexus Pharmaceuticals, a Lincolnshire, Illinois-based specialty- and generic-drug manufacturer of injectable drugs.   Lilly estimates…

Vertex Pharmaceuticals, a Boston-based bio/pharmaceutical company, and TreeFrog Therapeutics, a Bordeaux, France-based bio/pharmaceutical company, have formed a collaboration under which Vertex has obtained an exclusive license to TreeFrog’s proprietary cell-manufacturing…

Bristol Myers Squibb (BMS) and Cellares, a South San Francisco, California-based CDMO of cell therapies, have announced a worldwide capacity reservation and supply agreement for the manufacture of BMS’ CAR-T…

Fujifilm Corporation, the parent company of Fujifilm Diosynth Biotechnologies, has announced an additional investment of $1.2 billion to further expand Fujifilm’s Diosynth Biotechnologies biomanufacturing facility in Holly Springs, North Carolina,…